ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in Dallas, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Carcinoma
Hypersensitivity
Endometrial Cancer
Breast Cancer
Recurrence

Prostate Cancer trials near Dallas, TX, USA:

WATER IV Prostate Cancer (WATER IV PCa)

Therapy in men with low-risk to intermediate to high-risk localized prostate cancer who are candidates for, or have opted for, pros...

Begins enrollment this month
Localized Prostate Cancer
Device: Aquablation Therapy
Procedure: Radical Prostatectomy
PROCEPT BioRobotics

Dallas, Texas, United States and 22 other locations

pharmacodynamic (PD), and the preliminary efficacy of JANX007 administered as a single agent in adults with metastatic castration-resistant prostate...

Enrolling
Castration Resistant Prostatic Cancer
Metastatic Castration-resistant Prostate Cancer
Biological: JANX007

Phase 1

Janux Therapeutics

Dallas, Texas, United States and 15 other locations

single-arm, two-stage open-label phase 2 study of the combination of cabozantinib + nivolumab in subjects with advanced castration-resistant prostate...

Enrolling
Metastatic Cancer
Castration-resistant Prostate Cancer
Drug: Cabozantinib
Drug: Nivolumab

Phase 2

Rana McKay, MD

Dallas, Texas, United States and 3 other locations

radiation therapy for patients with intermediate-high risk localized prostate cancer. ProstAtak kills tumor cells and stim...

Active, not recruiting
Prostate Cancer
Biological: Placebo + valacyclovir
Biological: Aglatimagene besadenovec + valacyclovir

Phase 3

Candel Therapeutics

Dallas, Texas, United States and 72 other locations

to as AAA617. The study also seeks to further characterize (as possible) any other serious adverse reaction(s) in the long-term in adults with prostate...

Enrolling
Prostate Cancer
Drug: AAA617

Phase 4

Novartis
Novartis

Dallas, Texas, United States and 53 other locations

the safety and preliminary antitumor activity of ORIC-944 as a single agent and in combinations with ARPIs in patients with metastatic prostate...

Enrolling
Metastatic Prostate Cancer
Drug: Darolutamide (Nubeqa®) 300 mg tablets
Drug: ORIC-944

Phase 1

Oric Pharmaceuticals

Dallas, Texas, United States and 15 other locations

Confirming safety of combining UroLift System prior to SAbR for patients with newly diagnosed prostate cancer and a history of BPH,...

Enrolling
Prostate Cancer
Device: Urolift
Radiation: SABR

Phase 1

The University of Texas System (UT)
The University of Texas System (UT)

Dallas, Texas, United States

of the Vanquish Water Vapor Ablation Device ("Vanquish") in treating subjects with Gleason Grade Group 2 (GGG2) localized intermediate-risk prostate...

Enrolling
Prostate Cancer
Device: Vanquish System
Francis Medical

Dallas, Texas, United States and 32 other locations

Locations recently updated

The purpose of this study is to evaluate the efficacy and safety of apalutamide in adult men with high-risk non-metastatic castration-resistant prostate...

Active, not recruiting
Prostatic Neoplasms
Drug: Apalutamide
Drug: Placebo

Phase 3

Aragon Pharmaceuticals

Dallas, Texas, United States and 388 other locations

The purpose of this study is to collect long term safety data in subjects who are continuing to derive clinical benefit from treatment with Enzalutam...

Enrolling
Prostate Cancer
Drug: prednisone
Drug: enzalutamide

Phase 2

Astellas
Astellas

Dallas, Texas, United States and 234 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems